Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIEL DESJARDINS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1407379159
CMS profile
3165675
Location
WOODBINE, IA

General Payments · PY2018–2024

$1,768.65

  • Reported across 115 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$218.98

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $218.98 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Mylan Specialty L.P. $45.18 3
Bayer HealthCare Pharmaceuticals Inc. $28.58 2
ABBVIE INC. $27.29 1
Axsome Therapeutics, Inc. $22.90 1
Novo Nordisk AS $22.55 1
GlaxoSmithKline, LLC. $16.33 1
Acerta Pharma LLC $15.04 1
Amgen Inc. $13.91 1
Astellas Pharma US Inc $13.65 1
PFIZER INC. $13.55 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $24.56 2
PY2019 $27.99 1
PY2020 $230.91 15
PY2021 $519.39 37
PY2022 $344.02 22
PY2023 $402.80 25
PY2024 $218.98 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.29 06/28/2024 Food and Beverage Undisputed 01/23/2026 1103630332 CMS
Amgen Inc. $13.91 10/04/2024 Food and Beverage Undisputed 01/23/2026 1111562553 CMS
Astellas Pharma US Inc $13.65 04/03/2024 Food and Beverage Undisputed 01/23/2026 1139324662 CMS
AstraZeneca Pharmaceuticals LP $15.04 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104707395 CMS
Axsome Therapeutics, Inc. $22.90 02/21/2024 Food and Beverage Undisputed 01/23/2026 1148273899 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.04 02/02/2024 Food and Beverage Undisputed 01/23/2026 1086176446 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.54 08/14/2024 Food and Beverage Undisputed 01/23/2026 1086127616 CMS
GlaxoSmithKline, LLC. $16.33 01/19/2024 Food and Beverage Undisputed 01/23/2026 1116316894 CMS
Mylan Specialty L.P. $15.77 01/18/2024 Food and Beverage Undisputed 01/23/2026 1147311980 CMS
Mylan Specialty L.P. $13.53 05/20/2024 Food and Beverage Undisputed 01/23/2026 1147376632 CMS
Mylan Specialty L.P. $15.88 08/31/2024 Food and Beverage Undisputed 01/23/2026 1147295589 CMS
Novo Nordisk Inc $22.55 11/01/2024 Food and Beverage Undisputed 01/23/2026 1096620074 CMS
PFIZER INC. $13.55 09/11/2024 Food and Beverage Undisputed 01/23/2026 1131958415 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.